drugset / Trial / NCT00290550
A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a study to evaluate the effectiveness of an investigational drug in patients with cancer of the lung.
Timeline
- Start
- 2006-06
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TOZASERTIB | Small molecule | 10 mg/m2 | Intravenous |